VFPI
BBP icon

Vantage Financial Partners (Illinois)’s Virtus Biotech ETF BBP Stock Holding History

Vantage Financial Partners (Illinois)’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,700
Closed -$284K – 51
2016
Q4 		$284K Buy
+8,700
New +$285K 0.26% 40

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vantage Financial Partners (Illinois)'s BBP Position: Q1 2017 in Review

Vantage Financial Partners (Illinois) sold out of Virtus Biotech ETF (BBP) in Q1 2017, closing a stake of 8,700 shares — an estimated $284K sold.

Vantage Financial Partners (Illinois) first reported a position in BBP in Q4 2016 and held it in 1 quarter. The position peaked at $284K in Q4 2016. 18 funds tracked by Wall St. Rank hold BBP as of Q1 2017.

  • Vantage Financial Partners (Illinois) reported no remaining Virtus Biotech ETF position as of Q1 2017 after selling out during the quarter.
  • Vantage Financial Partners (Illinois) sold 8,700 Virtus Biotech ETF shares in Q1 2017, an estimated $284K.
  • Vantage Financial Partners (Illinois) first reported a position in Virtus Biotech ETF in Q4 2016 and held it in 1 quarter.
  • Vantage Financial Partners (Illinois)'s Virtus Biotech ETF position peaked at $284K in Q4 2016.
  • 18 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2017.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q1 2017, filed 12 May 2017.